AMN Life Science Private Limited — Ampicillin Exporter Profile
Indian Pharmaceutical Exporter · #4 for Ampicillin · $4.0M export value · DGFT Verified
AMN Life Science Private Limited is the #4 Indian exporter of Ampicillin with $4.0M in export value and 81 verified shipments. AMN Life Science Private Limited holds a 2.8% market share in Ampicillin exports across 2 countries. The company exports 2 pharmaceutical products worth $8.7M across 1 therapeutic categories.
AMN Life Science Private Limited — Ampicillin Export Profile: Buyers & Destinations
Where Does AMN Life Science Private Limited Export Ampicillin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MYANMAR | $3.3M | 75 | 96.0% |
| CAMBODIA | $138.2K | 6 | 4.0% |
AMN Life Science Private Limited exports Ampicillin to 2 countries. The largest destination is MYANMAR accounting for 96.0% of AMN Life Science Private Limited's Ampicillin shipments. These destinations reflect AMN Life Science Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ampicillin from AMN Life Science Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AORTA COMPANY LIMITED | MYANMAR | $3.3M | 74 |
| BAN BAN PHARMA | CAMBODIA | $113.2K | 5 |
| AORTA COMPANY LTD | MYANMAR | $50.0K | 1 |
| FAST MEDICARE PHARMA CO.,LTD | CAMBODIA | $25.0K | 1 |
AMN Life Science Private Limited supplies Ampicillin to 4 buyers globally. The largest buyer is AORTA COMPANY LIMITED (MYANMAR), followed by BAN BAN PHARMA (CAMBODIA) and AORTA COMPANY LTD (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ampicillin Export Value and How Much Does AMN Life Science Private Limited Contribute?
India exported $52.7M worth of Ampicillin through 4,470 shipments from 486 suppliers to 133 countries, serving 924 buyers globally. AMN Life Science Private Limited contributes $4.0M to this total, accounting for 2.8% of India's Ampicillin exports. AMN Life Science Private Limited ships Ampicillin to 2 countries through 4 buyers.
What Is the Average Shipment Value for AMN Life Science Private Limited's Ampicillin Exports?
AMN Life Science Private Limited's average Ampicillin shipment value is $50.0K per consignment, based on 81 shipments totaling $4.0M. The largest destination is MYANMAR (96.0% of AMN Life Science Private Limited's Ampicillin exports).
How Does AMN Life Science Private Limited Compare to Other Indian Ampicillin Exporters?
AMN Life Science Private Limited ranks #4 among 486 Indian Ampicillin exporters with a 2.8% market share. The top 3 exporters are STERISCIENCE SPECIALTIES PRIVATE LIMITED ($12.9M), SPARSH BIO-TECH PRIVATE LIMITED ($10.4M), AUROBINDO PHARMA LTD ($4.7M). AMN Life Science Private Limited processed 81 shipments to 2 destination countries.
What Ampicillin Formulations Does AMN Life Science Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AMNACLOXA(AMPICILLIN AND CLOXACILLIN CAP | $1.2M | 30 |
| AMNACLOXA (AMPICILLIN AND CLOXACILLIN CA | $200.0K | 4 |
| AMNACLOXA Ampicillin and Cloxacillin Ca | $162.4K | 4 |
| AMNACLOXA Ampicillin and Cloxacillin Capsules BP 250 mg 250mg+250mg 10X10PVC Blister PackQTY:24940 NOS 249400 | $100.0K | 2 |
| PHARMACEUTICAL GOODS : AMNACLOXA (AMPICILLIN AND CLOXACILLIN CAPSULES BP 250 MG)(250MG+250MG ) (10X10 PVC BLISTER PACK)KGS | $100.0K | 2 |
| PHARMACEUTICAL PRODUCTS:AMPICILLIN AND CLOXACILLIN CAPSULES BP (AMNACLOXA (10X 10 CAPSULES)(QTY:19994) | $100.0K | 2 |
| PHARMACEUTICAL PRODUCTS AMNACLOXA CAP AMPICILLIN CLOXACILLIN CAPSULE 250MG 250MG 10X10 ALU PVC BLISTER QTY 15104 | $80.0K | 2 |
| AMNACLOXA AMPICILLIN AND CLOXACILLIN CAPSULES BP 250 MG 250MG 250MG QTY 39840 3984000 CAPS | $50.0K | 1 |
| AMNACLOXAAMPICILLIN AND CLOXACILLIN CAP | $50.0K | 1 |
| AMNACLOXA Ampicillin and Cloxacillin Capsules BP 250 mg 250mg+250mg 10X10PVC Blister PackQTY:44860 NOS 448600 | $50.0K | 1 |
AMN Life Science Private Limited exports 42 distinct Ampicillin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AMNACLOXA(AMPICILLIN AND CLOXACILLIN CAP with 30 shipments worth $1.2M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does AMN Life Science Private Limited Compare to Nearest Ampicillin Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | AUROBINDO PHARMA LTD | $4.7M | 106 | 10 | $44.1K |
| 7 | MEDREICH LIMITED | $4.1M | 102 | 5 | $40.6K |
| 4 | AMN LIFE SCIENCE PRIVATE LIMITED ★ | $4.0M | 81 | 2 | $50.0K |
| 8 | KARNATAKA ANTIBIOTICS AND PHARMACEUTICALS LIMITED | $3.1M | 103 | 9 | $30.0K |
| 10 | SCOTT EDIL PHARMACIA LIMITED | $2.3M | 61 | 11 | $37.8K |
AMN Life Science Private Limited ranks #4 among 486 Indian Ampicillin exporters. Average shipment value of $50.0K compared to the market average of $108.4K. The closest competitors by value are AUROBINDO PHARMA LTD and MEDREICH LIMITED.
Which Indian Ports Ship Ampicillin Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 412 | 9.2% |
| DELHI AIR CARGO ACC (INDEL4) | 317 | 7.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 301 | 6.7% |
| SAHAR AIR | 259 | 5.8% |
| DELHI AIR | 233 | 5.2% |
| BANGALORE ICD | 226 | 5.1% |
| MUNDRA SEA | 205 | 4.6% |
| JNPT/ NHAVA SHEVA SEA | 204 | 4.6% |
What Other Antibiotics Products Does AMN Life Science Private Limited Export?
AMN Life Science Private Limited also exports these antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on AMN Life Science Private Limited's Ampicillin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like AMN Life Science. The Israel-Iran conflict has led to disruptions in the Red Sea shipping routes, causing significant delays and increased freight costs. These maritime challenges have the potential to impact up to $600 million in Indian pharmaceutical exports to the West Asia and North Africa (WANA) region. (pharmaceuticalcommerce.com)
In the United States, recent tariff implementations have introduced additional complexities. The imposition of tariffs on pharmaceutical imports has raised concerns about the competitiveness of Indian generics in the U.S. market. However, the subsequent withdrawal of tariffs on imported generic drugs in early October 2025 has provided some relief to Indian exporters. (medboundtimes.com)
The European Union's regulatory landscape is also evolving, with the implementation of the Falsified Medicines Directive (FMD) necessitating stringent compliance measures. For companies like AMN Life Science, ensuring adherence to these regulations is crucial to maintain market access and uphold their reputation in the EU market.
AMN Life Science Private Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, particularly from agencies like the U.S. Food and Drug Administration (FDA) and the World Health Organization (WHO). India, being a major exporter, has faced challenges related to quality compliance, with instances of substandard products affecting its reputation. In 2023, the US FDA conducted over 200 inspections in India, underscoring the emphasis on quality assurance. (fact.net.in)
For AMN Life Science, maintaining compliance with Good Manufacturing Practices (GMP) and securing approvals from international regulatory bodies are imperative. The company's ongoing efforts to obtain UK MHRA and SAHPRA approvals demonstrate its commitment to meeting global quality standards and expanding its market footprint. (sales.superagi.com)
About AMN Life Science Private Limited
AMN Life Science Private Limited exports 2 products worth $8.7M. Beyond Ampicillin, top products include Amoxicillin. View the complete AMN Life Science Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ampicillin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ampicillin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: AMN Life Science Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 81 individual customs records matching AMN Life Science Private Limited exporting Ampicillin, covering 42 formulations to 2 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 133+ countries, 924+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ampicillin Export Data from AMN Life Science Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for AMN Life Science Private Limited's Ampicillin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AMN Life Science Private Limited
Full Company Profile →
2 products · $8.7M total trade · 1 categories
Ampicillin Stats
Company Overview
Top Products by AMN Life Science Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for AMN Life Science Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ampicillin. For current shipment-level data, contact TransData Nexus.